All this talk of TA and support and Bollinger Bands....as if this is a company with assessable financial metrics, with revenue and contracts, with growth that has a history and therefore can be forecast into the future.
DR's "expectation" of FDA approval in Q2 might have been enough to stave off sub-one dollar PPS, but now that that time has passed, what's to stop a drop to .70?
Lower closing prices now mean that any FDA pop will also result in a lower high when approval day happens.
Persoanlly, I can't wait until we move beyond this purgatory of waiting and expecting, into selling and expanding.
News 
Market Data 
Discover 
AI
